Association of Lean Body Mass to Menopausal Symptoms: The Study of Women's Health Across the Nation

Overview

Journal Womens Midlife Health

Publisher Biomed Central

Date 2020 Sep 18

PMID 32944260

Citations 3

Authors

Rosanne Woods

Rebecca Hess

Carol Biddington

Marc Federico

Affiliations

Soon will be listed here.

Abstract

Background: The purpose of this study was to examine the association of lean body mass (LBM) to the development of vasomotor symptoms (VMS) as women transition through menopause.

Methods: This study is a secondary use of data available for public use from follow up visits six through 10 for participants in the Study of Women's Health Across the Nation. The study examined 2533 women, between the ages 42-52 years, each year over a10-year period. Data was modeled for associations of lean body mass and VMS. Changes in LBM since prior visit and since baseline were also modeled along with differences in means using binary logistic regression, adjusting for covariates.

Results: LBM was significantly associated to concurrent VMS ( = .036), percent change in LBM since prior visit ( = .003), percent change since baseline ( < .001), and overall means associations ( = .023). LBM was not significant for VMS at individual visit measures. In mixed regression modeling, time was significant ( < .0001) at all visits. The estimated probability of developing VMS decreases significantly as LBM increases.

Conclusions: Lean body mass is negatively associated with incident VMS. Our data suggests that maintaining higher levels of LBM during the menopausal transition may be protective against the development of VMS. Every woman will experience menopause in her life and the ability to potentially prevent the onset of specific symptoms through basic interventions, such as resistance training to increase lean body mass, may positively impact this large population.

Citing Articles

DXA-based appendicular composition measures in healthy aging Caucasian Greek women: a cross-sectional study.

Theodorou S, Theodorou D, Kigka V, Gkiatas I, Fotopoulos A Rheumatol Int. 2024; 44(9):1715-1723.

PMID: 38860993 DOI: 10.1007/s00296-024-05622-4.

Risedronate or Exercise for Lean Mass Preservation During Menopause: Secondary Analysis of a Randomized Controlled Trial.

Flores L, Kupzyk K, Waltman N, Beavers K, Bilek L JCSM Rapid Commun. 2022; 5(2):154-161.

PMID: 36186606 PMC: 9517955. DOI: 10.1002/rco2.59.

Associations of physical activity with sarcopenia and sarcopenic obesity in middle-aged and older adults: the Louisiana osteoporosis study.

Du Y, Xu T, Yin Z, Espinoza S, Xie Y, Gentry C BMC Public Health. 2022; 22(1):896.

PMID: 35513868 PMC: 9074188. DOI: 10.1186/s12889-022-13288-5.

References

Waetjen L, Johnson W, Xing G, Feng W, Greendale G, Gold E . Serum estradiol levels are not associated with urinary incontinence in midlife women transitioning through menopause. Menopause. 2011; 18(12):1283-90. PMC: 3308014. DOI: 10.1097/gme.0b013e31821f5d25. View

Thurston R, Chang Y, Mancuso P, Matthews K . Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation. Fertil Steril. 2013; 100(3):793-800. PMC: 3759568. DOI: 10.1016/j.fertnstert.2013.05.005. View

Stefanska A, Bergmann K, Sypniewska G . Metabolic Syndrome and Menopause: Pathophysiology, Clinical and Diagnostic Significance. Adv Clin Chem. 2015; 72:1-75. DOI: 10.1016/bs.acc.2015.07.001. View

Maggio da Fonseca A, Bagnoli V, Souza M, Azevedo R, de Barros Couto Jr E, Soares Jr J . Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol. 2012; 29(2):116-8. DOI: 10.3109/09513590.2012.730570. View

Sanchez-Rodriguez M, Zacarias-Flores M, Arronte-Rosales A, Correa-Munoz E, Mendoza-Nunez V . Menopause as risk factor for oxidative stress. Menopause. 2011; 19(3):361-7. DOI: 10.1097/gme.0b013e318229977d. View

Gallicchio L, Miller S, Kiefer J, Greene T, Zacur H, Flaws J . Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study. J Womens Health (Larchmt). 2013; 23(3):231-7. PMC: 3952652. DOI: 10.1089/jwh.2013.4526. View

Janssen I, Heymsfield S, Baumgartner R, Ross R . Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985). 2000; 89(2):465-71. DOI: 10.1152/jappl.2000.89.2.465. View

Gold E, Crawford S, Shelton J, Tepper P, Crandall C, Greendale G . Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN). Menopause. 2016; 24(1):9-26. PMC: 5177513. DOI: 10.1097/GME.0000000000000723. View

Takamura T, Kita Y, Nakagen M, Sakurai M, Isobe Y, Takeshita Y . Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities. Heliyon. 2017; 3(7):e00347. PMC: 5499104. DOI: 10.1016/j.heliyon.2017.e00347. View

10.

Lee J, Lee D . Muscle strength and quality are associated with severity of menopausal symptoms in peri- and post-menopausal women. Maturitas. 2013; 76(1):88-94. DOI: 10.1016/j.maturitas.2013.06.007. View

11.

Signorelli S, Neri S, Sciacchitano S, Di Pino L, Pia Costa M, Marchese G . Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas. 2005; 53(1):77-82. DOI: 10.1016/j.maturitas.2005.03.001. View

12.

Mendoza N, de Teresa C, Cano A, Godoy D, Hita-Contreras F, Lapotka M . Benefits of physical exercise in postmenopausal women. Maturitas. 2016; 93:83-88. DOI: 10.1016/j.maturitas.2016.04.017. View

13.

Zacarias-Flores M, Sanchez-Rodriguez M, Garcia-Anaya O, Correa-Munoz E, Mendoza-Nunez V . Relationship between oxidative stress and muscle mass loss in early postmenopause: an exploratory study. Endocrinol Diabetes Nutr (Engl Ed). 2018; 65(6):328-334. DOI: 10.1016/j.endinu.2018.01.009. View

14.

Messier V, Rabasa-Lhoret R, Barbat-Artigas S, Elisha B, Karelis A, Aubertin-Leheudre M . Menopause and sarcopenia: A potential role for sex hormones. Maturitas. 2011; 68(4):331-6. DOI: 10.1016/j.maturitas.2011.01.014. View

15.

Zapantis G, Santoro N . The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab. 2003; 17(1):33-52. DOI: 10.1016/s1521-690x(02)00081-7. View

16.

Kazlauskaite R, Innola P, Karavolos K, Dugan S, Avery E, Fattout Y . Abdominal adiposity change in white and black midlife women: The study of women's health across the nation. Obesity (Silver Spring). 2015; 23(12):2340-3. PMC: 4704864. DOI: 10.1002/oby.21350. View

17.

Lukaski H, Johnson P, Bolonchuk W, Lykken G . Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985; 41(4):810-7. DOI: 10.1093/ajcn/41.4.810. View

18.

Maltais M, Desroches J, Dionne I . Changes in muscle mass and strength after menopause. J Musculoskelet Neuronal Interact. 2009; 9(4):186-97. View

19.

Tanaka N, Hanawa S, Murakami H, Cao Z, Tanimoto M, Sanada K . Accuracy of segmental bioelectrical impedance analysis for predicting body composition in pre- and postmenopausal women. J Clin Densitom. 2014; 18(2):252-9. DOI: 10.1016/j.jocd.2014.07.002. View

20.

Herber-Gast G, Mishra G, van der Schouw Y, Brown W, Dobson A . Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause. 2013; 20(9):953-9. DOI: 10.1097/GME.0b013e3182844a7c. View